Clinical Validation of the Aptima Bacterial Vaginosis and Aptima <i>Candida/Trichomonas</i> Vaginitis Assays: Results from a Prospective Multicenter Clinical Study
Jane R. Schwebke(University of Alabama at Birmingham), Craig B. Clark(Hologic (United States)), Paul Nyirjesy(Drexel University), Byron McKinney(Biogen (United States)), Neil B. Quigley(Maryville College), Ronald Ackerman, Charlotte A. Gaydos(Johns Hopkins University), Carmelle V. Remillard(Hologic (United States)), Steven Chavoustie(Segal Institute for Clinical Research), Damon Getman(Hologic (United States)), Robert Schlaberg(University of Utah), Stephanie N. Taylor(Louisiana State University Health Sciences Center New Orleans), Philip Estes(Hologic (United States))
Cited by 67
Related Papers
Rescue of the Cardiac Defect in ErbB2 Mutant Mice Reveals Essential Roles of ErbB2 in Peripheral Nervous System Development
|Neuron|1999|320
Current patient perspectives of vulvovaginal candidiasis: incidence, symptoms, management and post-treatment outcomes
|BMC Women s Health|2019|263
The Incidence and Correlates of Symptomatic and Asymptomatic Chlamydia trachomatis and Neisseria gonorrhoeae Infections in Selected Populations in Five Countries
|Sexually Transmitted Diseases|2011|221
Host–vaginal microbiota interactions in the pathogenesis of bacterial vaginosis
|Current Opinion in Infectious Diseases|2019|197
Gene structure of mammalian acetylcholinesterase. Alternative exons dictate tissue-specific expression.
|Journal of Biological Chemistry|1991|185